SCHEMBL9944987

SCHEMBL9944987

CNc1cc(N2CCOCC2)c(C(=O)N[C@H]2CC[C@H](C)CC2)cc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CNR1 P21554 4/20 0.43
CNR2 P34972 4/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
BMPR1B O00238 1/20 0.41
BMPR1A P36894 1/20 0.41
TGFBR1 P36897 1/20 0.41
ACVRL1 P37023 1/20 0.41
ACVR1 Q04771 1/20 0.41
USP30 Q70CQ3 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
TYK2 P29597 1/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944826 0.90 RAB9A (0.41) ALDH1A1CNR1CNR2NPC1RAB9A
SCHEMBL9944913 0.90 RAB9A (0.43) ALDH1A1CNR1CNR2NPC1RAB9A
SCHEMBL9947032 0.88 PTGES (0.46) ALDH1A1LMNATSHRHTTNPSR1
SCHEMBL9946870 0.88 PTGES (0.46) ALDH1A1LMNATSHRHTTNPSR1
SCHEMBL9944950 0.87 RAB9A (0.40) ALDH1A1CNR1CNR2NPC1RAB9A
SCHEMBL9945029 0.87 NPC1 (0.40) ALDH1A1CNR1CNR2NPC1RAB9A
SCHEMBL9944957 0.86 RAB9A (0.40) ALDH1A1CNR1CNR2NPC1RAB9A
SCHEMBL9944907 0.86 RAB9A (0.42) CNR1CNR2NPC1RAB9ABMPR1B
SCHEMBL9944932 0.86 RAB9A (0.40) ALDH1A1CNR2NPC1RAB9ATSHR
SCHEMBL9944740 0.86 RAB9A (0.41) ALDH1A1CNR1CNR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885CNR1 66/4885CNR2 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.